Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1688-1702

  Verma, Dinesh ^a   Li, Da Jiang ^a   Krueger, Brian ^b,d   Renne, Rolf ^b   Swaminathan, Sankar ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HIGH THROUGHPUT SEQUENCING; HUMAN HERPESVIRUS 8; NONHUMAN; OPEN READING FRAME; POLYADENYLATION; PROMOTER REGION; RNA SEQUENCE; UPREGULATION; VIRION; VIRUS ASSEMBLY; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE; CELL LINE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; PHYSIOLOGY; RNA STABILITY; VIRUS ENTRY; VIRUS RELEASE;

HUMAN HERPESVIRUS 8;

CELL LINE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; RNA STABILITY; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84921494163     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02663-14     Document Type: Article

References (50)

1. Ganem D. 2007. Kaposi's sarcoma-associated herpesvirus, p 2847-2888. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT. 1999. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73:4181-4187.
3. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340:1063-1070.
4. Han Z, Swaminathan S. 2006. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J Virol 80:5251-5260. http://dx.doi.org/10.1128/JVI.02570-05.
5. Majerciak V, Pripuzova N, McCoy JP, Gao SJ, Zheng ZM. 2007. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus. J Virol 81:1062-1071. http://dx.doi.org/10.1128/JVI.01558-06.
6. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM. 2011. Kaposi's sarcomaassociated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol 85:1528-1540. http://dx.doi.org/10.1128/JVI.01709-10.
7. Majerciak V, Yamanegi K, Allemand E, Kruhlak M, Krainer AR, Zheng ZM. 2008. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J Virol 82:2792-2801. http://dx.doi.org/10.1128/JVI.01856-07.
8. Nekorchuk M, Han Z, Hsieh TT, Swaminathan S. 2007. Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export. J Virol 81:9990-9998. http://dx.doi.org/10.1128/JVI.00896-07.
9. Hunter OV, Sei E, Richardson RB, Conrad NK. 2013. Chromatin immunoprecipitation and microarray analysis suggest functional cooperation between Kaposi's sarcoma-associated herpesvirus ORF57 and KbZIP. J Virol 87:4005-4016. http://dx.doi.org/10.1128/JVI.03459-12.
10. Malik P, Blackbourn DJ, Cheng MF, Hayward GS, Clements JB. 2004. Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins. J Gen Virol 85:2155-2166. http://dx.doi.org/10.1099/vir.0.79784-0.
11. Malik P, Blackbourn DJ, Clements JB. 2004. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J Biol Chem 279:33001-33011. http://dx.doi.org/10.1074/jbc.M313008200.
12. Sahin BB, Patel D, Conrad NK. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog 6:e1000799. http://dx.doi.org/10.1371/journal.ppat.1000799.
13. Stubbs SH, Hunter OV, Hoover A, Conrad NK. 2012. Viral factors reveal a role for REF/Aly in nuclear RNA stability. Mol Cell Biol 32:1260-1270. http://dx.doi.org/10.1128/MCB.06420-11.
14. Kirshner JR, Lukac DM, Chang J, Ganem D. 2000. Kaposi's sarcomaassociated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 74:3586-3597. http://dx.doi.org/10.1128/JVI.74.8.3586-3597.2000.
15. Boyne JR, Colgan KJ, Whitehouse A. 2008. Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication. PLoS Pathog 4:e1000194. http://dx.doi.org/10.1371/journal.ppat.1000194.
16. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J 29:1851-1864. http://dx.doi.org/10.1038/emboj.2010.77.
17. Jackson BR, Boyne JR, Noerenberg M, Taylor A, Hautbergue GM, Walsh MJ, Wheat R, Blackbourn DJ, Wilson SA, Whitehouse A. 2011. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export. PLoS Pathog 7:e1002138. http://dx.doi.org/10.1371/journal.ppat.1002138.
18. Verma D, Kim EA, Swaminathan S. 2013. Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs. J Virol 87:10742-10751. http://dx.doi.org/10.1128/JVI.01644-13.
19. Gupta AK, Ruvolo V, Patterson C, Swaminathan S. 2000. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J Virol 74:1038-1044. http://dx.doi.org/10.1128/JVI.74.2.1038-1044.2000.
20. Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, Hammerschmidt W, Sergeant A. 2002. Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol 76:9635-9644. http://dx.doi.org/10.1128/JVI.76.19.9635-9644.2002.
21. Sacks WR, Greene CC, Aschman DP, Schaffer PA. 1985. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol 55:796-805.
22. Cohen JI, Krogmann T, Ross JP, Pesnicak L, Prikhod'ko EA. 2005. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. J Virol 79:6969-6975. http://dx.doi.org/10.1128/JVI.79.11.6969-6975.2005.
23. Hayashi ML, Blankenship C, Shenk T. 2000. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc Natl Acad Sci U S A 97:2692-2696. http://dx.doi.org/10.1073/pnas.050587597.
24. Sato B, Sommer M, Ito H, Arvin AM. 2003. Requirement of varicellazoster virus immediate-early 4 protein for viral replication. J Virol 77:12369-12372. http://dx.doi.org/10.1128/JVI.77.22.12369-12372.2003.
25. Yakushko Y, Hackmann C, Gunther T, Ruckert J, Henke M, Koste L, Alkharsah K, Bohne J, Grundhoff A, Schulz TF, Henke-Gendo C. 2011. Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J Virol 85:4612-4617. http://dx.doi.org/10.1128/JVI.02068-10.
26. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
27. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. http://dx.doi.org/10.1016/j.jviromet.2011.03.012.
28. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197. http://dx.doi.org/10.2144/000112096.
29. Ruvolo V, Wang E, Boyle S, Swaminathan S. 1998. The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression. Proc Natl Acad Sci U S A 95:8852-8857. http://dx.doi.org/10.1073/pnas.95.15.8852.
30. Li DJ, Verma D, Swaminathan S. 2012. Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication. J Virol 86:9866-9874. http://dx.doi.org/10.1128/JVI.01190-12.
31. Bai Z, Huang Y, Li W, Zhu Y, Jung JU, Lu C, Gao SJ. 2014. Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs. J Virol 88:377-392. http://dx.doi.org/10.1128/JVI.02689-13.
32. Li DJ, Verma D, Mosbruger T, Swaminathan S. 2014. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription. PLoS Pathog 10:e1003880. http://dx.doi.org/10.1371/journal.ppat.1003880.
33. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. http://dx.doi.org/10.1186/gb-2010-11-10-r106.
34. Haas BJ, Papanicolaou A, Yassour M, Grabherr M, Blood PD, Bowden J, Couger MB, Eccles D, Li B, Lieber M, Macmanes MD, Ott M, Orvis J, Pochet N, Strozzi F, Weeks N, Westerman R, William T, Dewey CN, Henschel R, Leduc RD, Friedman N, Regev A. 2013. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat Protoc 8:1494-1512. http://dx.doi.org/10.1038/nprot.2013.084.
35. Han Z, Verma D, Hilscher C, Dittmer DP, Swaminathan S. 2009. General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein. J Virol 83:11635-11644. http://dx.doi.org/10.1128/JVI.01483-09.
36. Scotto-Lavino E, Du G, Frohman MA. 2006. 3' end cDNA amplification using classic RACE. Nat Protoc 1:2742-2745. http://dx.doi.org/10.1038/nprot.2006.481.
37. Myoung J, Ganem D. 2011. Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J Virol 85:9767-9777. http://dx.doi.org/10.1128/JVI.05136-11.
38. Sei E, Conrad NK. 2011. Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity. Virology 419:107-116. http://dx.doi.org/10.1016/j.virol.2011.08.006.
39. O'Grady T, Cao S, Strong MJ, Concha M, Wang X, Splinter Bondurant S, Adams M, Baddoo M, Srivastav SK, Lin Z, Fewell C, Yin Q, Flemington EK. 2014. Global bidirectional transcription of the Epstein-Barr virus genome during reactivation. J Virol 88:1604-1616. http://dx.doi.org/10.1128/JVI.02989-13.
40. Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, Holdorf M, Weissman JS, Ganem D. 2014. KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog 10:e1003847. http://dx.doi.org/10.1371/journal.ppat.1003847.
41. Majerciak V, Yamanegi K, Zheng ZM. 2006. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J Virol 80:11968-11981. http://dx.doi.org/10.1128/JVI.01394-06.
42. Majerciak V, Ni T, Yang W, Meng B, Zhu J, Zheng ZM. 2013. A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection. PLoS Pathog 9:e1003749. http://dx.doi.org/10.1371/journal.ppat.1003749.
43. McClure LV, Kincaid RP, Burke JM, Grundhoff A, Sullivan CS. 2013. Comprehensive mapping and analysis of Kaposi's sarcoma-associated herpesvirus 3' UTRs identify differential posttranscriptional control of gene expression in lytic versus latent infection. J Virol 87:12838-12849. http://dx.doi.org/10.1128/JVI.02374-13.
44. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862-14867. http://dx.doi.org/10.1073/pnas.93.25.14862.
45. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM. 2011. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol 85:2620-2630. http://dx.doi.org/10.1128/JVI.02144-10.
46. Davison A. 2007. Comparative analysis of the genomes. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
47. Spiller OB, Robinson M, O'Donnell E, Milligan S, Morgan BP, Davison AJ, Blackbourn DJ. 2003. Complement regulation by Kaposi's sarcomaassociated herpesvirus ORF4 protein. J Virol 77:592-599. http://dx.doi.org/10.1128/JVI.77.1.592-599.2003.
48. Conrad NK, Mili S, Marshall EL, Shu MD, Steitz JA. 2006. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol Cell 24:943-953. http://dx.doi.org/10.1016/j.molcel.2006.10.029.
49. Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM. 2011. Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci 7:1145-1160. http://dx.doi.org/10.7150/ijbs.7.1145.
50. Palmeri D, Spadavecchia S, Carroll KD, Lukac DM. 2007. Promoterand cell-specific transcriptional transactivation by the Kaposi's sarcomaassociated herpesvirus ORF57/Mta protein. J Virol 81:13299-13314. http://dx.doi.org/10.1128/JVI.00732-07.